<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04199312</url>
  </required_header>
  <id_info>
    <org_study_id>ZA19-001</org_study_id>
    <nct_id>NCT04199312</nct_id>
  </id_info>
  <brief_title>Magnetic Muscle Stimulation of Abdominal Muscle</brief_title>
  <acronym>MMS</acronym>
  <official_title>Magnetic Muscle Stimulation of Abdominal Muscle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zeltiq Aesthetics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zeltiq Aesthetics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the safety and efficacy of magnetic muscle stimulation (MMS) of abdominal muscle.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 4, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy Endpoint: Body Satisfaction Scale (BSS)</measure>
    <time_frame>one-month post final treatment</time_frame>
    <description>Change in subject perception of body shape as measured using the Body Satisfaction Scale (BSS) at the one-month post-final-treatment follow-up visit.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>Muscle Toning, Firming and Strengthening</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The EMS device will be evaluated for muscle toning, firming and strengthening in the abdomen.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The ZELTIQ System</intervention_name>
    <description>The MMS device will be used to perform the treatments.</description>
    <arm_group_label>Muscle Toning, Firming and Strengthening</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Male or female ≥ 22 years and ≤65 years of age.

          -  Subject has not had weight change exceeding 5% of body weight in the preceding month.

          -  Subject agrees to maintain body weight within 5% during the study by not making any
             changes in diet or exercise routine.

          -  Subject has a BMI ≤ 30 as determined at screening.

          -  Subject agrees to have photographs taken of the treatment area(s) during the scheduled
             time periods.

          -  Subject agrees to have MRI during the scheduled time periods.

          -  Subject agrees to refrain from any new abdominal muscle training exercises of the
             treatment area during the course of the study.

          -  Subject agrees to avoid sun tanning during the course of the study.

          -  Subject has read and signed the study written informed consent form.

        Exclusion Criteria

          -  Subject has had a recent surgical procedure(s) in the area of intended treatment and
             muscle contractions may disrupt the healing process.

          -  Subject has had an invasive fat reduction procedure (e.g., liposuction, mesotherapy)
             in the area of intended treatment.

          -  Subject has had a non-invasive fat reduction procedure (e.g. CoolSculpting, SculpSure)
             in the area of intended treatment within the past 6 months.

          -  Subject needs to administer or has a known history of subcutaneous injections into the
             area of intended treatment (e.g., heparin, insulin) within the past month.

          -  Subject has had an intrauterine contraceptive device inserted or removed within the
             past month.

          -  Subject has a bleeding disorder or hemorrhagic condition

          -  Subject is taking or has taken diet pills or supplements within the past month.

          -  Subject has an active implanted electrical device such as a cardiac pacemaker,
             cochlear implant, intrathecal pump, hearing aids, defibrillator, or drug delivery
             system

          -  Subject has metal or electronic implants in or adjacent to the treatment area

          -  Subject has an abdominal hernia

          -  Subject has pulmonary insufficiency.

          -  Subject has a cardiac disorder.

          -  Subject has a malignant tumor.

          -  Subject has been diagnosed with a seizure disorder such as epilepsy.

          -  Subject currently has a fever.

          -  Subject is diagnosed with Grave's disease.

          -  Subject has a growth plate in the treatment area

          -  Subject is pregnant or intending to become pregnant during the study period (in the
             next 9 months).

          -  Subject is lactating or has been lactating in the past 6 months.

          -  Subject has any contraindications to MRI (e.g. metal implant, history of metal work or
             metal slivers in eye, prone to severe claustrophobia).

          -  Subject is unable or unwilling to comply with the study requirements.

          -  Subject is currently enrolled in a clinical study of any unapproved investigational
             device, investigational product or any other type of medical research judged not to be
             scientifically or medically compatible with this study.

          -  Any other condition or laboratory value that would, in the professional opinion of the
             Investigator, potentially affect the subject's response or the integrity of the data
             or would pose an unacceptable risk to the subject.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kerrie Jiang, NP</last_name>
    <role>Study Director</role>
    <affiliation>Zeltiq Aesthetics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tonia N Madere</last_name>
    <phone>925-474-2537</phone>
    <email>tonia.madere@allergan.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Investigate MD</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85255</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenna Sanford</last_name>
      <phone>480-440-5985</phone>
      <email>jsanford@investigatemd.com</email>
    </contact>
    <investigator>
      <last_name>Brenda LaTowsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Innovation Research Center</name>
      <address>
        <city>Pleasanton</city>
        <state>California</state>
        <zip>94588</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Laser and Skin Surgery Center of Northern California</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>December 3, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

